Navigating Old and New Therapies for Vitiligo: What’s Working Now, What’s Not, and What’s Next
With the availability of new therapies for vitiligo, such as the topical Janus kinase (JAK) inhibitor ruxolitinib (Opzelur...
Continue with Facebook
Sign up with your email
Become a member to get even more